Short-Acting β 2 -Agonist Use Could Be a Confounding Factor for Interpreting Increased IL-6

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of respiratory and critical care medicine 2020-11, Vol.202 (9), p.1324-1324
1. Verfasser:	Nannini, Luis J
Format:	Artikel
Sprache:	eng
Schlagworte:	Adrenergic beta-2 Receptor Antagonists - adverse effects Adrenergic beta-2 Receptor Antagonists - therapeutic use Asthma - drug therapy Humans Interleukin-6 - blood
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	1324
container_issue	9
container_start_page	1324
container_title	American journal of respiratory and critical care medicine
container_volume	202
creator	Nannini, Luis J
description
doi_str_mv	10.1164/rccm.202006-2297LE
format	Article
fullrecord	<record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1164_rccm_202006_2297LE</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>32687403</sourcerecordid><originalsourceid>FETCH-LOGICAL-c663-adc1f06287d34f3b1e5e151a578c68a99a10a8b012d8225caaabf7488a8a31a33</originalsourceid><addsrcrecordid>eNo9kEtOwzAQhi0EoqVwARbIF3DxK7azLFULkSKxoEgskKKJH6WoTSo7XXAtDsKZSAmwGM2_mO_X6EPomtEpY0reRmt3U045pYpwnutycYLGLBMZkbmmp32mWhAp85cRukjpnVLGDaPnaCS4MlpSMUavT29t7MjMdptmjb8-Mcdktm6bTerwc_J43h62Dt95DH1sQnto3PFwCbZrIw79FE3n4z76n4KisdFD8g4XJVGX6CzANvmr3z1Bq-ViNX8g5eN9MZ-VxColCDjLAlXcaCdkEDXzmWcZg0wbqwzkOTAKpu6fd4bzzAJAHbQ0BgwIBkJMEB9qbWxTij5U-7jZQfyoGK2OpqqjqWowVQ2meuhmgPaHeufdP_KnRnwD86xkyA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Short-Acting β 2 -Agonist Use Could Be a Confounding Factor for Interpreting Increased IL-6</title><source>MEDLINE</source><source>American Thoracic Society (ATS) Journals Online</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Nannini, Luis J</creator><creatorcontrib>Nannini, Luis J</creatorcontrib><identifier>ISSN: 1073-449X</identifier><identifier>EISSN: 1535-4970</identifier><identifier>DOI: 10.1164/rccm.202006-2297LE</identifier><identifier>PMID: 32687403</identifier><language>eng</language><publisher>United States</publisher><subject>Adrenergic beta-2 Receptor Antagonists - adverse effects ; Adrenergic beta-2 Receptor Antagonists - therapeutic use ; Asthma - drug therapy ; Humans ; Interleukin-6 - blood</subject><ispartof>American journal of respiratory and critical care medicine, 2020-11, Vol.202 (9), p.1324-1324</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c663-adc1f06287d34f3b1e5e151a578c68a99a10a8b012d8225caaabf7488a8a31a33</cites><orcidid>0000-0002-9868-9883</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4025,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32687403$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nannini, Luis J</creatorcontrib><title>Short-Acting β 2 -Agonist Use Could Be a Confounding Factor for Interpreting Increased IL-6</title><title>American journal of respiratory and critical care medicine</title><addtitle>Am J Respir Crit Care Med</addtitle><subject>Adrenergic beta-2 Receptor Antagonists - adverse effects</subject><subject>Adrenergic beta-2 Receptor Antagonists - therapeutic use</subject><subject>Asthma - drug therapy</subject><subject>Humans</subject><subject>Interleukin-6 - blood</subject><issn>1073-449X</issn><issn>1535-4970</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kEtOwzAQhi0EoqVwARbIF3DxK7azLFULkSKxoEgskKKJH6WoTSo7XXAtDsKZSAmwGM2_mO_X6EPomtEpY0reRmt3U045pYpwnutycYLGLBMZkbmmp32mWhAp85cRukjpnVLGDaPnaCS4MlpSMUavT29t7MjMdptmjb8-Mcdktm6bTerwc_J43h62Dt95DH1sQnto3PFwCbZrIw79FE3n4z76n4KisdFD8g4XJVGX6CzANvmr3z1Bq-ViNX8g5eN9MZ-VxColCDjLAlXcaCdkEDXzmWcZg0wbqwzkOTAKpu6fd4bzzAJAHbQ0BgwIBkJMEB9qbWxTij5U-7jZQfyoGK2OpqqjqWowVQ2meuhmgPaHeufdP_KnRnwD86xkyA</recordid><startdate>20201101</startdate><enddate>20201101</enddate><creator>Nannini, Luis J</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0002-9868-9883</orcidid></search><sort><creationdate>20201101</creationdate><title>Short-Acting β 2 -Agonist Use Could Be a Confounding Factor for Interpreting Increased IL-6</title><author>Nannini, Luis J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c663-adc1f06287d34f3b1e5e151a578c68a99a10a8b012d8225caaabf7488a8a31a33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adrenergic beta-2 Receptor Antagonists - adverse effects</topic><topic>Adrenergic beta-2 Receptor Antagonists - therapeutic use</topic><topic>Asthma - drug therapy</topic><topic>Humans</topic><topic>Interleukin-6 - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nannini, Luis J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>American journal of respiratory and critical care medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nannini, Luis J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Short-Acting β 2 -Agonist Use Could Be a Confounding Factor for Interpreting Increased IL-6</atitle><jtitle>American journal of respiratory and critical care medicine</jtitle><addtitle>Am J Respir Crit Care Med</addtitle><date>2020-11-01</date><risdate>2020</risdate><volume>202</volume><issue>9</issue><spage>1324</spage><epage>1324</epage><pages>1324-1324</pages><issn>1073-449X</issn><eissn>1535-4970</eissn><cop>United States</cop><pmid>32687403</pmid><doi>10.1164/rccm.202006-2297LE</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-9868-9883</orcidid></addata></record>
fulltext	fulltext
identifier	ISSN: 1073-449X
ispartof	American journal of respiratory and critical care medicine, 2020-11, Vol.202 (9), p.1324-1324
issn	1073-449X 1535-4970
language	eng
recordid	cdi_crossref_primary_10_1164_rccm_202006_2297LE
source	MEDLINE; American Thoracic Society (ATS) Journals Online; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects	Adrenergic beta-2 Receptor Antagonists - adverse effects Adrenergic beta-2 Receptor Antagonists - therapeutic use Asthma - drug therapy Humans Interleukin-6 - blood
title	Short-Acting β 2 -Agonist Use Could Be a Confounding Factor for Interpreting Increased IL-6
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T01%3A29%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Short-Acting%20%CE%B2%202%20-Agonist%20Use%20Could%20Be%20a%20Confounding%20Factor%20for%20Interpreting%20Increased%20IL-6&rft.jtitle=American%20journal%20of%20respiratory%20and%20critical%20care%20medicine&rft.au=Nannini,%20Luis%20J&rft.date=2020-11-01&rft.volume=202&rft.issue=9&rft.spage=1324&rft.epage=1324&rft.pages=1324-1324&rft.issn=1073-449X&rft.eissn=1535-4970&rft_id=info:doi/10.1164/rccm.202006-2297LE&rft_dat=%3Cpubmed_cross%3E32687403%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/32687403&rfr_iscdi=true